EHE — Estia Health Share Price
0.000.00%
Last trade - 00:00HealthcareBalancedMid Cap
- AU$795.75m
- AU$900.61m
- AU$754.30m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 20.09 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | 10.08% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.59 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 6.34 | ||
| Price to Sales | 1.05 | ||
| EV to EBITDA | 6.85 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.79% | ||
| Return on Equity | -6.5% | ||
| Operating Margin | 0.73% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 585.99 | 636.91 | 646.3 | 671.07 | 754.3 | 869.8 | 940.42 | 6.64% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +0.65 | n/a | n/a | n/a | n/a | n/a | +12.41 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Estia Health Limited is an Australia-based creator of residential aged care homes. The Company is engaged in the provision of services in residential aged care homes. The Company operates approximately 72 homes, including 25 homes in Victoria, 19 homes in South Australia, 18 homes in New South Wales and 10 homes in Queensland. These homes have approximately 6,596 operational places. The Company operates single rooms. It cares for approximately 8,000 residents every year. The Company provides short-term respite care, long-term care, dementia care, palliative care and emergency care. Respite care offers a short-term option for people requiring care and for their care givers that may need a break. The Company operates its homes across various locations, such as Aberfoyle Park, Albany Creek, Albury, Altona Meadows, Ardeer, Bannockburn, Benalla, Dandenong, Epping, Wattle Glen, Lockleys, Flagstaff Hill, Knoxfield, Melton South, and others.
Directors
- Gary Weiss NEC (68)
- Ian Thorley CEO
- Sean Bilton DCE
- Steve Lemlin CFO
- Lisa Keogh CHO
- Fiona Caldwell CIO
- Leanne Laidler CRO
- Mark Brandon OTH
- Damian Hiser OTH
- Rita Sheridan OTH
- Leanne Ralph SEC
- Norah Barlow NED
- Paul Foster NID
- Helen Kurincic NID
- Karen Penrose NID
- Warwick Smith NID
- Last Annual
- June 30th, 2023
- Last Interim
- June 30th, 2023
- Incorporated
- October 29th, 2012
- Public Since
- December 5th, 2014
- No. of Shareholders
- 5,088
- No. of Employees
- 8,220
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 258,361,034
- Address
- Level 9, 227 Elizabeth Street, SYDNEY, 2000
- Web
- https://www.estiahealth.com.au/
- Phone
- +61 300682833
- Auditors
- Ernst & Young
Upcoming Events for EHE
Half Year 2024 Estia Health Ltd Earnings Release
Similar to EHE
Apiam Animal Health
Australian Stock Exchange - SEATS
Artrya
Australian Stock Exchange - SEATS
Australian Clinical Labs
Australian Stock Exchange - SEATS
Cann
Australian Stock Exchange - SEATS
Capitol Health
Australian Stock Exchange - SEATS
FAQ
What is the Estia Health share price?
As of Today at 18:08 UTC, shares in Estia Health are trading at AU$3.08. This share price information is delayed by 15 minutes.
How has the Estia Health share price performed this year?
Shares in Estia Health last closed at AU$3.08 and the price had moved by +49.51% over the past 365 days. In terms of relative price strength the Estia Health share price has outperformed the ASX All Ordinaries Index by +45.4% over the past year.
What are the analyst and broker recommendations for Estia Health?
The overall consensus recommendation for Estia Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Estia Health dividend yield?
The Estia Health dividend yield is 5.1% based on the trailing twelve month period.
Does Estia Health pay a dividend?
Last year, Estia Health paid a total dividend of AU$0.16, and it currently has a trailing dividend yield of 5.1%. We do not have any data on when Estia Health is to next pay dividends.
When does Estia Health next pay dividends?
We do not have data on when Estia Health is to next pay dividends. The historic dividend yield on Estia Health shares is currently 5.1%.
How do I buy Estia Health shares?
To buy shares in Estia Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Estia Health?
As of the previous close price of AU$3.08, shares in Estia Health had a market capitalisation of AU$795.75m.
Where are Estia Health shares listed?
Here are the trading details for Estia Health:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: EHE
What kind of share is Estia Health?
Based on an overall assessment of its quality, value and momentum Estia Health is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Estia Health share price forecast for 2023?
The analyst consensus target price for shares in Estia Health is AU$3.20. That is 3.9% above the last closing price of AU$3.08.
Analysts covering Estia Health currently have a consensus Earnings Per Share (EPS) forecast of AU$0.15 for the next financial year.
Find out moreWhat is the trend in the Estia Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Estia Health. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +3.6%.
As of the last closing price of AU$3.08, shares in Estia Health were trading +9.44% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Estia Health PE Ratio?
The Estia Health PE ratio based on its reported earnings over the past 12 months is 20.09. The shares last closed at AU$3.08.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Estia Health?
Estia Health's management team is headed by:
- Gary Weiss - NEC
- Ian Thorley - CEO
- Sean Bilton - DCE
- Steve Lemlin - CFO
- Lisa Keogh - CHO
- Fiona Caldwell - CIO
- Leanne Laidler - CRO
- Mark Brandon - OTH
- Damian Hiser - OTH
- Rita Sheridan - OTH
- Leanne Ralph - SEC
- Norah Barlow - NED
- Paul Foster - NID
- Helen Kurincic - NID
- Karen Penrose - NID
- Warwick Smith - NID